Volume : 09, Issue : 10, October – 2022
Title:
06.IN SILICO SCREENING OF POTENTIAL DRUG (PHYTOCHEMICALS) AGAINST INTERLEUKIN-6 THE KEY PROTEIN INVOLVED IN METASTASIS
Authors :
Kiruthika Balasubramnian, Sathishkumar R, Senthil Praphu
Abstract :
Cancer is not a single disease. It’s a group of diseases characterized by the uncontrolled growth of cells which results in tumors. The cells from the tumor at one point will start spreading to other organs which are termed metastasis. Mostly 90 percent of cancer patients die due to metastasis. A lot of treatments fail because of the complexity of cancer. The cancer cells can keep on mutating to adapt to the new environment. There are many different treatments available for cancer. But the most common ones are radiotherapy and chemotherapy. Both treatments can kill the cancer cells most often they end up killing the normal cells too. Then reduced sensitivity of the cancer cells to these treatments particularly in the advanced stages of cancer leads to ineffective treatment. The release of secretory factors from the cancer cells confers resistance to the cancer cells against therapy. Interleukin 6 which is found to be high in the tumor microenvironment regulates different signaling pathways and confers resistance to the cancer cells against damage. There are a lot of natural phytochemicals which can block interleukin 6 and thereby block metastasis. In this study, we selected 80 phytochemicals and studied their interaction capacity with the Interleukin -6. The phytochemicals were analyzed using molecular docking studies ADME-properties, and drug-likeness using the Schrodinger software. The phytochemicals were then analyzed using different software like protox and toxpro to study the anticarcinogenic, immunogenic, and genotoxic effects as well as the toxicity effects. The phytochemical Secoisolariciresinol has significantly interacted with active residues and it is an Interleukin -6 antagonist according to the protox II app too, which supports our results.
Keywords: Phytochemicals, Interleukin -6, protox2, ADMET, Molecular docking, Protox-II, Stoptox, Secoisolariciresinol
Cite This Article:
Please cite this article in Kiruthika Balasubramnian et al, In Silico Screening Of Potential Drug (Phytochemicals) Against Interleukin-6 The Key Protein Involved In Metastasis., Indo Am. J. P. Sci, 2022; 09(10).
Number of Downloads : 10
References:
1. Sung H, Ferlay J.,Siegel R L.,Laversanne M.,Soerjomataram I.,Jemal A and Bray F.(2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin . 2021 ;71(3):209-249. doi: 10.3322/caac.21660.
2. Pratheeshkumar P., Son Y., Korangath P.,Manu K A., and Siveen K A, ,Phytochemicals in Cancer Prevention and Therapy. Biomed Res Int. 2015; 324021.doi: 10.1155/2015/324021.
3. Kiruthika B and Padma P R, Anticancer Activity of Zea Mays Leaf Extracts on Oxidative Stress-induced Hep2 Cells. J Acupunct Meridian Stud.2013; 6(3):149-158.
4. Bobba S, Ponnaluri V K C.,, Mukherji M., Gutheil W G., Microtiter plate-based assay for inhibitors of penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother . 2011; 55(6):2783-7. doi: 10.1128/AAC.01327-10. Epub 2011 Mar 14.
5. Jayatilaka H., Tyle P., Chen J J., Kwak M., Ju J., Kim H J., Lee J SH., Wu P H., Gilkes D M ., Fan R., Wirtz D., Synergistic IL-6 and IL-8 paracrine signalling pathway infers a strategy to inhibit tumour cell migration.N P G.2017 8(1) :1-12.
6. Kumari N, Dwarakanath B S , Das A, Bhatt A N.(2016) Role of interleukin-6 in cancer progression and therapeutic resistance.Tumour Biol. 2016;37(9):11553-11572. doi: 10.1007/s13277-016-5098-7. Epub 2016 Jun 3.
7. Brabek J., Jakubek M., Vellieux F., Novotný J., Kolar M., Lacina L., Szabo P., Strnadová K., Rösel D., Dvořánková B and Smetana K., Jr, Interleukin-6: Molecule in the Intersection of Cancer, Ageing and COVID-19, 2020, Int J Mol Sci.; 21(21): 7937.
8. Chun J Y., Tummala R., Nadiminty N., Lou W., Liu Chengfei., Yang J., Evans C P., Zhou Q and Gao A C, Andrographolide, an Herbal Medicine, Inhibits Interleukin-6 Expression and Suppresses Prostate Cancer Cell Growth, 2010, Genes Cancer. 2010 ; 1(8): 868–876.
9. Borba J V V B., Alves V., Braga R., Korn D., Overdahl K., Silva AC., Hall S., Overdahl E., Strickland J., Allen D., Kleinstreuer N., Andrade c and Muratov E ., STopTox: An In-Silico Alternative to Animal Testing for Acute Systemic and topical toxicity, 9Th Brazilian Symposium on Medicinal Chemistry,2019; 1, – 111469 430.D O I: 10.26434/chemrxiv.13283930.v1
10. Niu W., Wu F., Cao W., Wu Z., Chao Y and Chun Liang, Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6, Biosci Rep. 2021; 29;41(1):BSR20202583. doi: 10.1042/BSR20202583.
11. Malik A., Naz A., Ahmad S., Hafeez M., Awan FM., Jafar TH., Zahid A., Ikram A., Rauff B and Hassan , M Inhibitory Potential of Phytochemicals on Interleukin-6- Mediated T-Cell Reduction in COVID-19 Patients: A Computational Approach. 2021;doi: 10.1177/11779322211021
12. Li J., Mckay K T., Remington J M and Schneebeli S T., A computational study of cooperative binding to multiple SARS-CoV-2 proteins, Scientific Reports.2021 ;11: 16307.
13. Ghandadi,M., and Sahebkar,A.(2017).Curcumin: An Effective Inhibitor of Interleukin-6.Review Curr Pharm Des,23(6):921-931. doi: 10.2174/1381612822666161006151605.
14. Zhong,M.,Cheng,G.F.,Wang,W.J.,Guo,Y.,Zhu,X.Y., and Zhang,J.T.(1999). Inhibitory effect of resveratrol on interleukin 6 release by stimulated peritoneal macrophages of mice, Phytomedicine,6(2):79-84. doi: 10.1016/S0944-7113(99)80039-7.
15. Li,J., Huang,W., Zhang,H.,Wang,X and Zhou,H.(2007), Synthesis of andrographolide derivatives and their TNF-α and IL-6 expression inhibitory activities Bioorg Med Chem Lett,17(24):6891-4. doi: 10.1016/j.bmcl.2007.10.009.
16. Mueller,M., Hobiger,S. and Jungbauer,A.(2010). Anti-inflammatory activity of extracts from fruits, herbs and spices,Food Chem., 122, 4, 987-996
17. Ahmed, S., Marotte, H., Kwan, K., Ruth, J.H., Campbell, P.L., Rabquer, B.J., Pakozdi, A. and Koch, A.E (2008).Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses trans-signaling by enhancing soluble gp130 production, Proc Natl Acad Sci U S A.,105(38):14692-7. doi: 10.1073/pnas.0802675105. Epub 2008 Sep 16.
18. Vedin,I., Cederholm,T., Levi,Y,F.,Basun,H., Garlind,A, Irving,G.F., Jönhagen,M.E,Vessby,B., Wahlund, L., Palmblad,J.(2008) Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study,Am J Clin Nutr, 87(6):1616-22. doi: 10.1093/ajcn/87.6.1616.
19. Knijff, E.M., Breunis, M.N., Kupka, R.W., de Wit, H.J., Ruwhof, C., Akkerhuis, G.W, Nolen, W.A., and Drexhage, H.A.(2007), An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: restoration by lithium treatment,9(7):743-53. doi: 10.1111/j.1399-5618.2007.00444.x.
20. Kumari.N., Dwarakanath, B.S., Das, A., Bhatt, A.N. (2016), Role of interleukin-6 in cancer progression and therapeutic resistance,37(9):11553-11572. doi: 10.1007/s13277-016-5098-7. Epub 2016 Jun 3
21. Kiruthika, B., Vidhya, A., Sudhadevi, M and Padma. P.R.(2014) Zea Mays leaf extracts exhibit anticancer property and enhance the chemotherapeutic action of Etoposide in Cancer cells,4(3),1530-1539.